Mandate

Vinge has advised CAREL Industries S.p.A in connection with acquisition

CAREL Industries S.p.A has entered into a binding agreement to acquire 82.4% stake in Kiona Holding AS, a leading Norwegian Software as a Service (“SaaS”) provider of prop-tech solutions for energy consumption optimization and building digitalization in retail & industrial refrigeration, public, commercial and multi-residential facilities. The acquisition consideration implies a 100% enterprise value of NOK 2,350,000,000 (c. SEK 2,428,255,000).

Vinge acted as counsel to CAREL with respect to Swedish matters in the transaction. Vinge advised CAREL alongside Thommessen.

CAREL, based in Italy and listed on the Milan stock exchange, is a global leader in the design, production and marketing of technologically advanced components and solutions for excellent energy efficiency in the control of heating, ventilation, and air conditioning (HVAC) and refrigeration equipment and systems.

Vinge’s team consisted mainly of Henrik Borna (M&A / IT), Niklas Törnell (M&A), Jonatan Karlsson (M&A) and Sophia Reutercrona (Employment).

 

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025